• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » NeuroStar’s Latest TMS System: 19 Minutes Is the New 40

NeuroStar’s Latest TMS System: 19 Minutes Is the New 40

July 1, 2017
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
NeuroStar just announced that the FDA has cleared an updated version of its TMS system. Called the NeuroStar Advanced Therapy System, its primary claim to fame is that patients can receive a full TMS treatment in only 19 minutes, as opposed to the 40 minutes required with NeuroStar’s original system.

How was NeuroStar able to slim down the treatment time? The company tells us it trimmed the resting interval between bursts of magnetic pulses from 26 seconds to 11.

While a 19-minute treatment time sounds like a curious number to hype in marketing efforts, there is a logic to the company’s calculus. NeuroStar’s main competitor in the TMS world is the Brainsway device (http://www.brainsway.com/us), a “deep” TMS device that has been touting its 20-minute treatment duration. Compared to the old NeuroStar, 20 minutes sounded Flash Gordon–like, but the Advanced system now beats Brainsway to the finish line by a full 60 seconds.

Will this attract more psychiatrists to the NeuroStar hardware? Possibly. Some practitioners have told TCPR that, anecdotally, Brainsway seems a little more effective than NeuroStar... but there are no head-to-head trials to settle the question. And Brainsway causes more side effects, such as jaw, face, and tongue spasms—a clear disadvantage from the perspective of patient ­experience.

Don’t forget that there are two other entrants in the TMS horse race: Magstim (https://www.magstim.com/) and MagVenture (http://www.magventure.com/en-gb/). Gadgets are clearly thriving in psychiatry. For a deep dive into interventional psychiatry, see TCPR July/August 2015.
General Psychiatry
KEYWORDS depressive_disorder
Carlat 150x150
Daniel Carlat, MD

Treating Alcohol Use Disorder—A Fact Book (2023)

More from this author
www.thecarlatreport.com
Issue Date: July 1, 2017
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Antidepressants, TCPR, July/August 2017
Beginning Antidepressant Treatment: A Recommended Approach
When First-Line Depression Treatments Don’t Cut It: Newer Antidepressants and Sometimes, Antipsychotics
When Depression Meds Fail, Transcranial Magnetic Stimulation Might Be Plan B
ConsumerLab.com: Guiding Patients Toward OTCs That Won’t Hurt Them
NeuroStar’s Latest TMS System: 19 Minutes Is the New 40
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.